Zdrowie i gospodarka · 14/07/2026
FDA Announces Final Guidance for Clinical Investigations of Psychedelic Drugs
The US Food and Drug Administration (FDA) has released a final guidance document outlining considerations for industry sponsors developing psychedelic drugs for medical conditions, following a draft issued in June 2023.